News – Page 723 – Endpoints News

HHS postpones review of over 95% of FDA’s regulations so critical resources are not diverted from Covid-19

5 years ago

Idera squelches any lingering enthusiasm as its lead TLR9 drug flunks PhIII — badly

5 years ago

Drumroll, please: Fujifilm Diosynth picks North Carolina as new home for $2B cell-culture superplant

5 years ago

Drugmakers brace for a pricing fight as Xavier Becerra is confirmed as the next HHS secretary

5 years ago

Inside Novartis' months-long efforts to scale their rivals' Covid-19 vaccines

5 years ago

Recall report: Sagent Pharma pulls low blood pressure med for loose sealing on sterile vials

5 years ago

Catalent amps up plans to manufacture J&J's Covid-19 vaccine, adding vial filling line in Italy

5 years ago

Covid-19 manufacturing roundup: Catalent, AstraZeneca defend vaccine batch quality in safety row — FT; US buys more ...

5 years ago

EMA calls for AstraZeneca vaccinations to continue after safety scares delayed rollout

5 years ago

Merck KGaA adds 350 workers at French site to build capacity for 'single-use' tech for Covid-19 vaccines, therapies

5 years ago

Gilead and Novo Nordisk expand NASH deal with new study; Pfizer out-licenses ADCs to a biotech startup

5 years ago

Living in its post-Shire world, Takeda continues aggressive licensing push in $2.3B deal with Anima

5 years ago

Top biotech investor Peter Kolchinsky tees up a new SPAC — 3 days after a $300M raise for radiopharmaceuticals play

5 years ago

Pfizer lays down its hand on Chinese biosims, offloading its 3-year-old plant to WuXi Biologics as competition grows

5 years ago

Roger Perlmutter’s latest ‘retirement’ gig opens a door to the bustling China biotech scene

5 years ago

CAR-M era begins as Carisma doses first patient

5 years ago

Covid-19 roundup: Facing supply delay, UK fires shot at Europe after EU threatens to ban AstraZeneca vaccine exports

5 years ago

Are radiopharmaceuticals ready for the mainstream? Novartis, Bristol Myers Squibb bet yes on MPM's platform take

5 years ago

Got a revolutionary healthcare company? Bob Nelsen, Jeff Leiden’s SPAC has $500M to take it public

5 years ago

Little Apellis is arming itself for a David and Goliath battle over a blockbuster drug franchise

5 years ago

Eli Lilly’s Covid-19 drug bamlanivimab is no longer distributed in 3 states because of a variant, Woodcock says

5 years ago

Lack of early efficacy for Translate Bio's mRNA-based cystic fibrosis drug raises some big questions

5 years ago

Denied top job, Mike Nally exits chief marketing job at Merck as the big C-suite shakeup continues

5 years ago

New Purdue bankruptcy plan roundly criticized as Sacklers offer $4B+; Sana seals pact with Fujifilm for iPSC-derived ...

5 years ago

First page Previous page 720 721 722723724 725 726 Next page Last page